Maryland's Drug Price Gouging Law: The Potential Consequences

NCPA Senior Fellow Thomas Hemphill writes at RealClear Health:
On May 26, Maryland became the first state to pass a law which applies specifically to “price gouging” practices by generic pharmaceutical manufacturers of essential drugs.  This law passed with overwhelming bipartisan support, 137-2-2 in the Maryland House of Delegates, and 38-7-2 in the Maryland Senate, had more than enough votes to override the Governor’s veto.  Maryland Governor Larry Hogan (R), in a letter to the speaker of the Maryland House, explained that he withheld his signature because the bill vaguely defines what constitutes “price gouging” and may not withstand a legal challenge on constitutional grounds. 
Continue readingFor more on Health Issues: http://www.ncpa.org/sub/dpd/?Article_Category=16

Continue Reading....

Check Also

The Silly Appeal of Expanding Medicare for All

Facebook Twitter Google+ Pinterest LinkedIn Digg Del StumbleUpon E-mail Reddit Buffer Love ThisSenior Fellow Devon …

Leave a Reply

Send this to friend